Across TCGA pan-cancer cohorts, MIR412 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR412 data layer compared with 12 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR412 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR412 expression acts as an unfavorable survival marker.

LUAD are the cancer types where MIR412 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.004	0.835	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR412 tumor-vs-normal RNA expression · all MIR412 data types